Stay updated on Illumina Press Releases

Sign up to get notified when there's something new on the Illumina Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Illumina Press Releases page

  1. Check
    3 days ago
    Change Detected
    Summary
    Illumina has announced its upcoming Fourth Quarter and Full Year 2024 financial results scheduled for February 6, 2025, and has advanced its NovaSeq X Series with new capabilities for multiomic applications.
    Difference
    100%
    Check dated 2025-01-12T17:44:34.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    BiotechTV reported on Illumina's new MiSeq i100 series of benchtop sequencers unveiled at an Innovation Day event, while a previous article about Illumina's updated tumor research assay has been removed.
    Difference
    75%
    Check dated 2024-12-22T01:32:52.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Recent additions highlight significant advancements in genomic medicine, including safe newborn screening by genome sequencing and a breakthrough in whole human genome sequencing in Nigeria, while several articles on genomic profiling and cancer assays have been removed.
    Difference
    100%
    Check dated 2024-12-14T22:43:25.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Illumina has announced a webcast for an upcoming investor conference on December 4, 2024, while the preview of their newest innovations at the American Society of Human Genetics Annual Meeting on October 31, 2024, has been removed.
    Difference
    43%
    Check dated 2024-12-07T16:10:21.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    Recent updates include Illumina's preview of an updated tumor research assay and the incorporation of Myriad's Genomic Instability Score into its TSO 500 Cancer Assay, highlighting advancements in cancer genomics.
    Difference
    100%
    Check dated 2024-11-30T13:00:31.000Z thumbnail image
  8. Check
    53 days ago
    Change Detected
    Summary
    Recent updates highlight Illumina's expansion of the TruSight Oncology portfolio and significant advancements in comprehensive genomic profiling that enhance precision therapy and patient outcomes.
    Difference
    100%
    Check dated 2024-11-23T04:35:46.000Z thumbnail image

Stay in the know with updates to Illumina Press Releases

Enter your email address, and we'll notify you when there's something new on the Illumina Press Releases page.